BrentLWoodMDPhD

PubMed

• 8 citations
  Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid
  Keith R. Loeb, Sindhu Cherian, Pamela S. Becker, Roland B. Walter, John M. Pagel
  British Journal of Haematology. 2016-01-01
• 1298 citations
  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
  Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo
  Leukemia. 2022-07-01
• 1452 citations
  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
  Joseph D Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio
  Leukemia. 2022-07-01

Journal Articles

• Second Cycle Remission Achievement with 7+3 and Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials  
  Brent L Wood, Roland B Walter, John E Godwin, James K Weick, Elihu H Estey, Derek L Stirewalt, Frederick R Appelbaum, Nature
• Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology Group  
  Michael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood
• Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia  
  Michael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature

Abstracts/Posters

• Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Genomic Landscape of Childhood Acute Lymphoblastic Leukemia
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Comparative Analysis of Total Body Irradiation (TBI)-Based and Non-TBI-Based Myeloablative Conditioning for Acute Myeloid Leukemia in Remission with and without Measur...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Myelodysplastic Syndrome with Excess Blasts and Secondary Acute Myeloid Leukemia: Same Disease with Different Blast Count
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic ...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to Bcma CAR-T Cells Correlates with Pretreatment Target Antigen Density and Is Improved By Small Molecule Inhibition of Gamma Secretase
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcome in Adolescent and Young Adult (AYA) Patients Compared to Younger Patients Treated for High-Risk B-Lymphoblastic Leukemia (HR B-ALL): Report from the ChildrenÍs...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with N... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018